Mantle cell lymphoma trials in Belgium

2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 14 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantle-cell Lymphoma

  Where

  Bruges, Brussels, Liège, Yvoir

  Age

  18 years to 79 years

  People

  100 worldwide

  Run by

  The Lymphoma Academic Research Organisation

  See details and how to joinNCT06558604
• Phase 2/3Taking people
  A phase II, multicenter, open-label study evaluating Glofitamab in combination with Venetoclax plus Zanubrutinib or Venetoclax alone in subjects with untreated or relapsed/refractory high-risk mantle-cell lymphoma

  Where

  Anderlecht, Brugge, Liège, Yvoir

  Age

  18 years and over

  People

  100 worldwide

  Run by

  Lymphoma Academic Research Organisation

  See details and how to join2023-506706-40-00